While this association may be attributed to the effect of immunosuppressive therapy administered to PV patients, or as an immunological consequence associated with autoimmune disease, it appears plausible that the development of cancer in these patients could be partly attributed to the loss of Dsg3 function. This evidence concerns the gene DSG3 and cancer.